Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery
Recruiting
N/A
Interventional Study
Lung Cancer
Surgery
ERAS
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 350 (estimated)
- Sponsor
- The Second Hospital of Shandong University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively recent with limited outcome data. This study aimed to determine the impact of an Enhanced Recovery Surgery pathway on short- term and long- term results in patients undergoing lung resection for primary lung cancer.
Methods: A Randomized Controlled Trial was designed to collect the perioperative data on …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical resection or other benign lung lesions need VATS surgery.
\-
Exclusion Criteria: cardio-pulmonary function couldn't tolerate surgery
\-
Contacts